| PDF (746kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-268292
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26829
Alternative Links zum Volltext:Pubmed
Zusammenfassung
In a three-way cross-over study the bioavailability of cefuroxime was determined in 12 healthy volunteers after oral administration of 250 mg as cefuroxime axetil (Elobact; CAS 64544-07-6) in a plain aqueous suspension and as tablets from different batches. The tablet formulations showed nearly identical pharmacokinetic parameters and were bioequivalent. The mean maximum serum concentration was ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik